Impact of biological therapy on spondyloarthritis.

about

Impact of biological therapy on spondyloarthritis.

Item

http://www.wikidata.org/entity/Q38218614

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Impact of biological therapy on spondyloarthritis.

@en

type

Item

label

Impact of biological therapy on spondyloarthritis.

@en

prefLabel

Impact of biological therapy on spondyloarthritis.

@en

P1476

Impact of biological therapy on spondyloarthritis.

@en

P2093

Francesco Paolo Cantatore

http://www.w3.org/2001/XMLSchema#string

Nicola Maruotti

http://www.w3.org/2001/XMLSchema#string

P2860

Ankylosing spondylitis: an overview

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.

P2888

s00228-014-1706-x

P304

1021-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-014-1706-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023705688

http://www.w3.org/2001/XMLSchema#string

P698

24909930

http://www.w3.org/2001/XMLSchema#string

Impact of biological therapy on spondyloarthritis.

about

Impact of biological therapy on spondyloarthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698